The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice
- PMID: 39642881
- PMCID: PMC11711001
- DOI: 10.1016/j.cmet.2024.11.003
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice
Abstract
Obesity is a chronic disease that contributes to the development of insulin resistance, type 2 diabetes (T2D), and cardiovascular risk. Glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR) and glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) co-agonism provide an improved therapeutic profile in individuals with T2D and obesity when compared with selective GLP-1R agonism. Although the metabolic benefits of GLP-1R agonism are established, whether GIPR activation impacts weight loss through peripheral mechanisms is yet to be fully defined. Here, we generated a mouse model of GIPR induction exclusively in the adipocyte. We show that GIPR induction in the fat cell protects mice from diet-induced obesity and triggers profound weight loss (∼35%) in an obese setting. Adipose GIPR further increases lipid oxidation, thermogenesis, and energy expenditure. Mechanistically, we demonstrate that GIPR induction activates SERCA-mediated futile calcium cycling in the adipocyte. GIPR activation further triggers a metabolic memory effect, which maintains weight loss after the transgene has been switched off, highlighting a unique aspect in adipocyte biology. Collectively, we present a mechanism of peripheral GIPR action in adipose tissue, which exerts beneficial metabolic effects on body weight and energy balance.
Keywords: GIP receptor; SERCA pathway; adipose tissue; energy expenditure; obesity; weight loss.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests R.J.S., V.P., K.A.C., C.J., and M.C. are current or past employees of Eli Lilly and Company. This does not alter the authors’ adherence to science journal policies on sharing data and materials.
References
-
- Anderson JW, Konz EC, Frederich RC, and Wood CL (2001). Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 74, 579–584. - PubMed
-
- van Rijswijk AS, van Olst N, Schats W, van der Peet DL, and van de Laar AW (2021). What Is Weight Loss After Bariatric Surgery Expressed in Percentage Total Weight Loss (%TWL)? A Systematic Review. Obes Surg 31, 3833–3847. - PubMed
-
- Kusminski CM, Bickel PE, and Scherer PE (2016). Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat Rev Drug Discov 15, 639–660. - PubMed
MeSH terms
Substances
Grants and funding
- RC1 DK086629/DK/NIDDK NIH HHS/United States
- P30 DK127984/DK/NIDDK NIH HHS/United States
- R03 DK135783/DK/NIDDK NIH HHS/United States
- P30 DK036836/DK/NIDDK NIH HHS/United States
- P01 AG051459/AG/NIA NIH HHS/United States
- RC2 DK116691/DK/NIDDK NIH HHS/United States
- K01 DK125447/DK/NIDDK NIH HHS/United States
- R01 DK099110/DK/NIDDK NIH HHS/United States
- R01 DK055758/DK/NIDDK NIH HHS/United States
- R01 DK127274/DK/NIDDK NIH HHS/United States
- RC2 DK118620/DK/NIDDK NIH HHS/United States
- P30 DK135043/DK/NIDDK NIH HHS/United States
- R01 DK131537/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical